Uracil in DNA and aberrant DNA methylation/hydroxymethylation as a new biomarkers of multiple myeloma development? A search for a possible link between genetic/epigenetic DNA modifications and multiple myeloma evolution.
2020/39/B/NZ5/01099
Keywords
Descriptors
- NZ5_005: Diagnostyka chorób człowieka
- NZ5_007: Leczenie chorób człowieka
Panel
NZ5 – Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution
Uniwersytet Mikołaja Kopernika, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Wydział Farmaceutyczny
Voivodeship: kujawsko-pomorskie
Principal investigator (from the host institution)
Number of co-investigators in the project: 14
Call
OPUS 20 – announced on 2020-09-15
- Amount awarded
- 2 304 960 PLN
- Project start date
- 2021-10-08
- Project end date
- 2027-10-07
- Project duration
- 72 months (the same as in the proposal)
- Project status
- Pending project
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.